Works about INTERFERON beta-1a

Results: 262
    1

    JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 138, n. 3, p. 627, doi. 10.1007/s11060-018-2831-7
    By:
    • Wakabayashi, Toshihiko;
    • Natsume, Atsushi;
    • Mizusawa, Junki;
    • Katayama, Hiroshi;
    • Fukuda, Haruhiko;
    • Sumi, Minako;
    • Nishikawa, Ryo;
    • Narita, Yoshitaka;
    • Muragaki, Yoshihiro;
    • Maruyama, Takashi;
    • Ito, Tamio;
    • Beppu, Takaaki;
    • Nakamura, Hideo;
    • Kayama, Takamasa;
    • Sato, Shinya;
    • Nagane, Motoo;
    • Mishima, Kazuhiko;
    • Nakasu, Yoko;
    • Kurisu, Kaoru;
    • Yamasaki, Fumiyuki
    Publication type:
    Article
    2
    3
    4

    Multiple Sclerosis-like Lesions Induced by Radiation: A Case Report and Systematic Review of the Literature.

    Published in:
    Journal of Clinical Medicine, 2024, v. 13, n. 24, p. 7554, doi. 10.3390/jcm13247554
    By:
    • Sterpi, Angeliki-Erato;
    • Triantafyllou, Alexandros-Stavros;
    • Tzanetakos, Dimitrios;
    • Ampantzi, Eleni;
    • Kitsos, Dimitrios;
    • Theodorou, Aikaterini;
    • Koutsouraki, Effrosyni;
    • Maili, Maria;
    • Stefanou, Maria Ioanna;
    • Moschovos, Christos;
    • Palaiodimou, Lina;
    • Tzartos, John;
    • Giannopoulos, Sotirios;
    • Tsivgoulis, Georgios
    Publication type:
    Article
    5
    6
    7
    8
    9
    10

    Erratum.

    Published in:
    European Neurology, 2023, v. 86, n. 6, p. 430, doi. 10.1159/000535278
    Publication type:
    Article
    11
    12
    13
    14
    15
    16

    Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial.

    Published in:
    2020
    By:
    • Arabi, Yaseen M.;
    • Asiri, Ayed Y.;
    • Assiri, Abdullah M.;
    • Aziz Jokhdar, Hani A.;
    • Alothman, Adel;
    • Balkhy, Hanan H.;
    • AlJohani, Sameera;
    • Al Harbi, Shmeylan;
    • Kojan, Suleiman;
    • Al Jeraisy, Majed;
    • Deeb, Ahmad M.;
    • Memish, Ziad A.;
    • Ghazal, Sameeh;
    • Al Faraj, Sarah;
    • Al-Hameed, Fahad;
    • AlSaedi, Asim;
    • Mandourah, Yasser;
    • Al Mekhlafi, Ghaleb A.;
    • Sherbeeni, Nisreen Murad;
    • Elzein, Fatehi Elnour
    Publication type:
    journal article
    17

    Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development – (III) A Randomized Trial with Interferon Beta‐1a Products.

    Published in:
    Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 2, p. 339, doi. 10.1002/cpt.2784
    By:
    • Florian, Jeffry;
    • Gershuny, Victoria;
    • Sun, Qin;
    • Schrieber, Sarah J.;
    • Matta, Murali K.;
    • Hazel, Anthony;
    • Sheikhy, Morasa;
    • Weaver, James L.;
    • Hyland, Paula L.;
    • Hsiao, Cheng‐Hui;
    • Vegesna, Giri;
    • DePalma, Ryan;
    • Shah, Aanchal;
    • Prentice, Kristin;
    • Sanabria, Carlos;
    • Wang, Yow‐Ming;
    • Strauss, David G.
    Publication type:
    Article
    18

    Advancing Innovations in Biosimilars.

    Published in:
    Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 1, p. 11, doi. 10.1002/cpt.2782
    By:
    • Wang, Yow‐Ming;
    • Strauss, David G.
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25

    Retrospective analysis of effectiveness of fingolimod in real life setting in Turkey (REFINE).

    Published in:
    Turkish Journal of Medical Sciences, 2023, v. 53, n. 1, p. 323, doi. 10.55730/1300-0144.5588
    By:
    • TUNCER, Aslı;
    • KÜRTÜNCÜ, Murat;
    • TERZİ, Murat;
    • UYGUNOĞLU, Uğur;
    • GÖNCÜOĞLU, Cansu;
    • YÜCEYAR, Ayşe Nur;
    • EKMEKÇİ, Özgül;
    • TÜRKOĞLU, Recai;
    • SOYSAL, Aysun;
    • KÖSEOĞLU, Mesrure;
    • BOZ, Cavit;
    • BECKMANN, Yeşim;
    • TURAN, Ömer Faruk;
    • DEMİRKIRAN, Meltem;
    • AKMAN, Gülşen;
    • ALTUNRENDE, Burcu;
    • AYDIN CANTÜRK, İlknur;
    • BİRDAY, Erkingül;
    • ÖZCAN, Abdulcemal;
    • KAMIŞLI, Özden
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Treatment Strategies.

    Published in:
    Current Medical Literature: Multiple Sclerosis, 2015, v. 7, n. 1, p. 25
    Publication type:
    Article
    36

    Clinical Observations.

    Published in:
    Current Medical Literature: Multiple Sclerosis, 2014, v. 6, n. 3, p. 98
    Publication type:
    Article
    37
    38

    Treatment Strategies.

    Published in:
    Current Medical Literature: Multiple Sclerosis, 2012, v. 4, n. 3, p. 71
    Publication type:
    Article
    39
    40

    Adherence to self-administering interferon-β1a using RebiSmart® device in Mexican patients with relapsing multiple sclerosis.

    Published in:
    PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0230959
    By:
    • Sauri-Suárez, Sergio;
    • Quiñones-Aguilar, Sandra;
    • Contreras-Marín, Arturo;
    • Ramiro-Guerrero, Erik Omar;
    • Zúñiga-García, David;
    • Salinas-Vázquez, Leticia;
    • Llamas-López, Leonardo;
    • León-Jiménez, Carolina;
    • García-Martell, Adriana;
    • González-Hernández, Iliana;
    • Chiquete, Erwin;
    • García, Silvia
    Publication type:
    Article
    41
    42

    Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial.

    Published in:
    2021
    By:
    • Aricò, Eleonora;
    • Castiello, Luciano;
    • Bracci, Laura;
    • Urbani, Francesca;
    • Lombardo, Flavia;
    • Bacigalupo, Ilaria;
    • Ancidoni, Antonio;
    • Vanacore, Nicola;
    • Falcione, Alessandro;
    • Reggiani, Chiara;
    • Dutti, Giovanni Marco;
    • Maglie, Maria Grazia;
    • Papa, Ombretta;
    • Bartoletti, Pier Luigi;
    • Ozzella, Giuseppina;
    • Bevilacqua, Nazario;
    • Nicastri, Emanuele;
    • Belardelli, Filippo;
    • Sconocchia, Giuseppe
    Publication type:
    Letter
    43
    44
    45
    46
    47
    48
    49
    50

    Heterogeneity of treatment effect of interferon-β1b and lopinavir–ritonavir in patients with Middle East respiratory syndrome by cytokine levels.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-22742-8
    By:
    • Arabi, Yaseen M.;
    • Asiri, Ayed Y.;
    • Assiri, Abdullah M.;
    • Abdullah, Mashan L.;
    • Aljami, Haya A.;
    • Balkhy, Hanan H.;
    • Al Jeraisy, Majed;
    • Mandourah, Yasser;
    • AlJohani, Sameera;
    • Al Harbi, Shmeylan;
    • Jokhdar, Hani A. Aziz;
    • Deeb, Ahmad M.;
    • Memish, Ziad A.;
    • Jose, Jesna;
    • Ghazal, Sameeh;
    • Al Faraj, Sarah;
    • Al Mekhlafi, Ghaleb A.;
    • Sherbeeni, Nisreen Murad;
    • Elzein, Fatehi Elnour;
    • Hayden, Frederick G.
    Publication type:
    Article